Slovenian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Anticancer Research

Primitive neuroectodermal tumor (PNET) of the brain diagnosed during pregnancy.

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
Povezava se shrani v odložišče
Barbara Bodner-Adler
Klaus Bodner
Harald Zeisler

Ključne besede

Povzetek

BACKGROUND

Brain tumors in pregnancy are extremely rare events. A case of a patient with primitive neuroectodermal tumor (PNET) of the brain diagnosed during the second half of pregnancy is reported.

METHODS

The first case of PNET of the brain diagnosed in a 26-year-old woman, gravida 1 para 0, in her 20th week of pregnancy is presented. The patient presented with headache, nausea and blurred vision. Magnetic resonance imaging revealed a large ill-defined tumoral mass in the left frontal cortex. Gross subtotal resection was achieved via a left frontal craniotomy. Pathological evaluation revealed histology and immuno-histochemistry consistent with the diagnosis of PNET. Adjuvant radiation therapy to the neurocranium was administered. Additionally, chemotherapy with Temodal 5 mg (Temozolomid) was initiated at 30 weeks of gestation. The patient delivered her baby via Cesarean section at 34 weeks of gestation. After delivery, external beam radiation to the craniospinal axis completed the therapy. The patient is currently being followed-up at the Department of Oncology University of Vienna Medical School, without any evidence of disease, 3 months after diagnosis.

CONCLUSIONS

This case is the first reported description of a PNET in pregnancy. A brief discussion of this rare disease and its management in pregnancy is presented. The treatment options seem to be reduced in pregnant women and mainly depend on the patient's condition as well as the gestational age at presentation. In a multidisciplinary approach, an optimal therapy schedule should be assessed depending on these two parameters.

Pridružite se naši
facebook strani

Najbolj popolna baza zdravilnih zelišč, podprta z znanostjo

  • Deluje v 55 jezikih
  • Zeliščna zdravila, podprta z znanostjo
  • Prepoznavanje zelišč po sliki
  • Interaktivni GPS zemljevid - označite zelišča na lokaciji (kmalu)
  • Preberite znanstvene publikacije, povezane z vašim iskanjem
  • Iščite zdravilna zelišča po njihovih učinkih
  • Organizirajte svoje interese in bodite na tekočem z raziskavami novic, kliničnimi preskušanji in patenti

Vnesite simptom ali bolezen in preberite o zeliščih, ki bi lahko pomagala, vnesite zelišče in si oglejte bolezni in simptome, proti katerim se uporablja.
* Vse informacije temeljijo na objavljenih znanstvenih raziskavah

Google Play badgeApp Store badge